July 22, 2020 Press Releases

New Video Highlights Patients’ Struggle to Afford Prescriptions During COVID-19

WASHINGTON, DC —  In a new video, patients from across the country deliver a clear message: The COVID-19 pandemic hasn’t made the issue of high drug prices go away, it has made it worse. As millions of Americans have lost jobs and health insurance during the pandemic and pharmaceutical manufacturers continue to raise prices of critical drugs, patients share their fear of losing access to the medications they need to survive.


Saunta Anderson, Inglewood, CA, lives with rheumatoid arthritis: “If we were to lose insurance for any reason, my major medication would cost me $8,500 a month and that would be devastating for me.”

Angeline Jones, Argenta, IL, lives with partial complex epilepsy: “In order to live a seizure-free life, I essentially have to remain employed in order to afford my medication.”


Watch the video and read more about these patient stories here.

“In the midst of this pandemic, patients are coming together to share their stories and call for much-needed reform of our drug pricing system,” said Juliana Keeping, the communications director for Patients For Affordable Drugs and mother to a 7-year-old living with cystic fibrosis. “We are sharing our stories — those of fear, hope, and solidarity. Together our voices will drive change to ensure every American can afford the prescription drugs they need.”


Sneha Dave, Greenwood, IN, lives with ulcerative colitis: “We are still advocating for issues that are important to us.”

Travis Paulson, Eveleth, MN, lives with type 1 diabetes:“Nothing lasts forever. Not even hard times. So, we’ll get through this and we’ll make it.”


The video is the latest in a series of products released by Patients For Affordable Drugs that highlight taxpayers’ significant investment in COVID-19 vaccines and treatments and the impact the pandemic has had on patients.



Patients For Affordable Drugs is the only independent national patient organization focused exclusively on achieving policy changes to lower the price of prescription drugs.